Patent · US Active

Cross-linked hyaluronic acid grafted with dextran

US10131718B2 · kind B2 · utility

3Cited by

0References

33Claims

0Family size

Assignee

Galderma Holding SA · CH

Inventors

Anders Karlsson · Vaxholm, SE
Hotan MOJARRADI · Uppsala, SE

Key dates

Filing date	May 29, 2015
Grant date	Nov 20, 2018
Priority date	—
Expiry date	Nov 3, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC08J2351/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A hyaluronic acid product is comprising a cross-linked hyaluronic acid and one or more dextran molecules. The hyaluronic acid is cross-linked by ether bonds, and the one or more dextran molecules are covalently grafted to the cross-linked hyaluronic acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.